Effects of long-term treatment with testosterone enanthate in rhesus monkeys: I. Pharmacokinetics of testosterone, testicular volume and liver metabolism of testosterone

The effects of long-term administration of testosterone enanthate on the pharmacokinetics and bioavailability of testosterone were studied in adult male rhesus monkeys (n = 9), injected with 50 mg of testosterone enanthate (TE) once every 14 days for a total of 32 months. Control animals were injected with 0.2 mL olive oil. Serum testosterone levels increased sharply within 24 h of the first injection of TE and reached a peak on day 3 followed by a sharp decline, but baseline values were not reached even by day 14. Subsequent injections of TE caused a similar pharmacokinetic profile until the 55th injection; testosterone levels on day 3 declined from the 56 to 58th injection and remained in a lower range until the last injection. Repeated injections of TE increased the bioavailability of testosterone as shown by the Area Under the Curve. The nocturnal (22.00 h) surge in testosterone levels during the pretreatment phase was abolished by TE injections. TE injections altered the metabolism of testosterone by the liver, as studied in vitro; while liver from control animals converted testosterone to androstenedione as the major metabolite, androsterone was the major metabolite in chronically TE-treated animals. Spermatogenesis and the associated increase in testicular volume observed in control animals in winter were suppressed in TE-treated animals. The results indicate that repeated TE injections elevate serum testosterone to supra-physiological levels with marked fluctuations in circulating testosterone levels after each injection. Possibly in response to these elevated levels, there was a change in the metabolism of testosterone by the liver as observed in vitro.     

Alteration of epididymal function and its relation to maturation of spermatozoa

Alteration of epididymal function and its relation to maturation of spermatozoa was studied in 54 adult male albino rats. Levels of free and bound sialic acid in the spermatozoa and luminal contents of the epididymis and vas deferens were determined. A group of 10 received rabbit antiserum to ovine luteinizing hormone (LHAS) sc .2 ml/day for 5 days. 2 groups of 8 animals each received 2.5 mg cyproterone acetate twice daily for either 15 or 30 days. 16 animals served as intact controls and 12 animals served as castrate controls. Epididymis and vas deferens sperm counts were not affected by LHAS for 5 days or by cyproterone acetate for 15 days; however, sperm counts were decreased in the corpus (p less than .02), cauda (p less than .05), epididymidis and vas deferens (p less than .01) when rats were treated with cyproterone acetate for 30 days. Castration resulted in a marked reduction in all regions within 5 days. In the intact rats spermatozoa sialic acid decreased in the cauda epididymidis (p less than .01) and increased in the vas deferens (p less than .001). Sialic acid concentration was similar in those treated with either LHAS or cyproterone acetate for 30 days. Bound sialic acid in the epididymal fluid increased (p less than .02) to a maximum in the corpus and cauda and decreased in the vas deferens (p less than .05). LHAS or cyproterone acetate caused a reduction in bound sialic acid in the fluid of the epididymis and vas deferens.